Liver function study aims to guide dosing of new antifungal drug
NCT ID NCT05582187
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study looked at how a single dose of the antifungal drug fosmanogepix is handled by the body in 28 adults with varying degrees of liver impairment. Participants took one pill, and researchers measured drug levels in the blood over time. The goal was to understand if liver function affects drug clearance and safety, which helps doctors decide on proper dosing for patients with liver issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Genesis Clinical Research, LLC
Tampa, Florida, 33603, United States
-
Inland Empire Liver Foundation
Rialto, California, 92337, United States
Conditions
Explore the condition pages connected to this study.